You are here

Gilead's remdesivir gets US FDA approval for hospitalised Covid-19 patients

nz_remdesivir_231050.jpg
The US Food and Drug Administration (FDA) on Thursday approved Gilead Sciences' antiviral drug remdesivir for treating patients hospitalised with Covid-19, making it the first and only drug approved for the disease in the United States.

[WASHINGTON] The US Food and Drug Administration (FDA) on Thursday approved Gilead Sciences' antiviral drug remdesivir for treating patients hospitalised with Covid-19, making it the first and only drug approved for the disease in the United States.

Remdesivir, given intravenously, was...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes